Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hertzog

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|October 9, 2002
Development and validation of a stability-indicating HPLC method for the simultaneous determination of losartan potassium, hydrochlorothiazide, and their degradation productsDeanne L Hertzog, Jennifer Finnegan McCafferty, Xueguang Fang, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 27, 2007
Effects of the probiotic formulation VSL#3 on colitis in weanling ratsLeo R Fitzpatrick, Kristy L Hertzog, Angela L Quatse, et al.
Investigative Ophthalmology & Visual Science|July 1, 1993
Ablation rates and surface ultrastructure of 193 nm excimer laser keratectomiesM Campos, X W Wang, L Hertzog, et al.
Journal of Gerontological Nursing|March 28, 2002
Patterns of telephone use among nursing home residentsS H Gueldner, C A Smith, M Neal, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2006
Novel benzimidazole-based MCH R1 antagonistsAndrew J Carpenter, Kamal A Al-Barazanji, Kevin K Barvian, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2017
Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonistSteven M Sparks, Christopher Aquino, Pierette Banker, et al.
Plant Biology (Stuttgart, Germany)|December 17, 2019
Plant functional trait response to environmental drivers across European temperate forest understorey communitiesS L Maes, M P Perring, L Depauw, et al.
Journal of Medicinal Chemistry|November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|October 9, 2002
Development and validation of a stability-indicating HPLC method for the simultaneous determination of losartan potassium, hydrochlorothiazide, and their degradation productsDeanne L Hertzog, Jennifer Finnegan McCafferty, Xueguang Fang, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 27, 2007
Effects of the probiotic formulation VSL#3 on colitis in weanling ratsLeo R Fitzpatrick, Kristy L Hertzog, Angela L Quatse, et al.
Investigative Ophthalmology & Visual Science|July 1, 1993
Ablation rates and surface ultrastructure of 193 nm excimer laser keratectomiesM Campos, X W Wang, L Hertzog, et al.
Journal of Gerontological Nursing|March 28, 2002
Patterns of telephone use among nursing home residentsS H Gueldner, C A Smith, M Neal, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2006
Novel benzimidazole-based MCH R1 antagonistsAndrew J Carpenter, Kamal A Al-Barazanji, Kevin K Barvian, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2017
Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonistSteven M Sparks, Christopher Aquino, Pierette Banker, et al.
Plant Biology (Stuttgart, Germany)|December 17, 2019
Plant functional trait response to environmental drivers across European temperate forest understorey communitiesS L Maes, M P Perring, L Depauw, et al.
Journal of Medicinal Chemistry|November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.
Pageof 3